Debut Plus

BSE · 542803

Vaxfab Enterprises Limited

64
₹165 Cr market cap
P/E
EPS
₹0
Book value
₹14.04
ROE
-10.6%
ROCE
-3.44%
Debt / equity
0.02

Revenue & net profit by period

Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.

014.6729.344458.67Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26
Revenue (₹ Cr) Net profit (₹ Cr)

Latest period: revenue ₹0 Cr with net profit ₹-6 Cr — a -1460% net margin, versus 56.85% the period before.

Shareholding

As of 2026-08-31

0%
promoter holding
  • Public99.96%
  • FII0.04%

2,929 shareholders on record

Promoter holding trend

Each disclosed period, oldest to newest

Not enough history.

52-week position

Where the current price sits in its yearly band

29.056472

The band spans 2.48× from low to high.

Risk flags

Derived from disclosed data

No flags raised by the data.

Peer comparison

Trading · ranked #171 of 674 by market cap · medians across 50 industry peers

P/E
vs 39.94 peer med
P/B
4.56vs 5.48 peer med
ROE %
-10.6vs 12.48 peer med
Margin %
-13.6vs 4.43 peer med
CompanyMkt capP/EP/BROEMargin
Adani Enterprises Limited₹4,14,150 Cr160.884.373.93%6.78%
Avenue Supermarts Limited₹2,40,548 Cr78.659.8312.14%4.29%
Trent Ltd.₹1,49,433 Cr81.7321.4124.62%8.64%
FSN E-Commerce Ventures Ltd.₹98,675 Cr370.4368.3713.87%2.41%
Vishal Mega Mart Limited₹47,649 Cr53.536.411.32%6.61%
Aegis Logistics Limited₹47,511 Cr37.977.8414.83%13.95%
Aditya Infotech Limited₹45,256 Cr94.8324.1419.61%9.77%
Premier Energies Limited₹44,224 Cr26.5610.2735.05%19.67%
Redington Limited₹30,778 Cr17.113.0314.67%1.33%
Honasa Consumer Limited₹15,361 Cr60.8710.8714.16%9.75%
Vaxfab Enterprises Limited(this company)₹165 Cr4.56-10.6%-13.6%

AI analysis

AI-generated · google/gemini-2.5-flash

Vaxfab Enterprises Limited has a market capitalization of Rs 153 Cr. The company reported revenue of Rs 16.75 Cr, with a negative profit margin of -353.5%. The debt-to-equity ratio is low at 0.02. The promoter holding is 0%, with public shareholding at 99.9%. The company's 52-week high was Rs 68 and its 52-week low was Rs 16.65. The stock is currently under LT-ASM (Additional Surveillance Measure) Stage 1.

Positives

  • +The debt-to-equity ratio is low at 0.02, indicating minimal reliance on borrowed capital.
  • +The number of shareholders has increased to 2977 in May 2026 from 513 in March 2020.

Negatives

  • The company reported a negative profit margin of -353.5%, indicating significant losses.
  • The Return on Equity (ROE) is negative at -10.6%, and Return on Capital Employed (ROCE) is also negative at -3.441%.
  • Promoter holding is 0% as of May 2026, a decrease from 25.7708% in March 2021.
  • The stock is under LT-ASM (Additional Surveillance Measure) Stage 1, which signifies potential price volatility or unusual trading activity.
  • There are no quarterly results disclosed since Dec 2025.

Financial Performance

In the latest annual reporting period, Vaxfab Enterprises Limited recorded a revenue of Rs 8.83 Cr in Mar 2026. Quarterly revenue for Dec 2025 was Rs 15.66 Cr, with a net profit of -3.24 Cr. The company's annual revenue for Mar 2025 was Rs 58.67 Cr, generating a net profit of Rs 0.7 Cr for that period.

Profitability & Returns

Vaxfab Enterprises Limited reported a negative Return on Equity (ROE) of -10.6% and a negative Return on Capital Employed (ROCE) of -3.441%. The company's profit margin stood at -353.5%. The earnings per share (EPS) for the latest period was 0.

Balance Sheet

The company maintains a low debt-to-equity ratio of 0.02. The book value per share is Rs 13.94. No dividend yield was reported for the current period.

Ownership & Pledges

As of May 31, 2026, promoter shareholding is 0%, while public shareholding stands at 99.9%. The number of shareholders is 2977. There are no reported promoter pledges.

Regulatory & Surveillance

Vaxfab Enterprises Limited is currently under LT-ASM (Additional Surveillance Measure) Stage 1, indicating increased scrutiny due to specific market parameters.

Data as of — price: 2026-09-12 · financials: Jun 26 · shareholding: Aug 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.

How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.

Back to Vaxfab Enterprises Limitedshare price & fundamentals